Larry P. Cote quoted in article “Trump’s Attorney General Pick Is Bad News for Legal Marijuana”
Below is an excerpt:
Larry Cote, a partner with the law firm Quarles & Brady and a leading Drug Enforcement Administration compliance attorney, said that he suspects Sessions will be a "strong opponent," within the Trump administration of "any efforts to...
Larry P. Cote quoted in article “This Is U-47700, Once a Lab Experiment, Now a Killer Opioid”
Below is an excerpt:
The U.S. government—including Congress and the DEA—has added more than 100 drugs to Schedule I, the category for chemicals the DEA says don’t have a medical purpose and pose a significant abuse risk, since passing the Controlled...
The Wall Street Journal
Quarles & Brady Moves Washington, D.C. Office Location
WASHINGTON, D.C. — The national law firm of Quarles & Brady LLP today announced that the firm's Washington, D.C. office has a new location. The firm is now located at 1701 Pennsylvania Avenue NW, Suite 700, Washington, D.C. 20006....
Larry P. Cote quoted in article “AMA Open To Discussing Mandatory Education For Opioid Prescribers”
Below is an excerpt:The American Medical Association told Inside Health Policy it is open to discussing the idea of mandatory opioid prescriber education tied to DEA registration as endorsed by several FDA advisers earlier this month, coming after the group...
Larry Cote quoted in article “FDA Adds Black-Box Warning To Opioids”
Below is an excerpt:Those additional steps include educating physicians on not prescribing too many pills at a time and ensuring medical schools teach physicians-in-training more about the dangers of opioids, Quarles & Brady LLP partner Larry Cote told Law360. For...
Larry Cote Joins Community Anti-Drug Coalitions of America’s Board of Directors
WASHINGTON, D.C. — The national law firm of Quarles & Brady LLP today announced that Washington, D.C. office managing partner, Larry Cote, has joined the Community Anti-Drug Coalitions of America's (CADCA) board of directors. CADCA offers youth...
Larry P. Cote quoted in article “7 Steps for Electronic Prescribing of Controlled Substances”
Below is an excerpt:7. Keep an eye on state and federal legal developments. In addition to state mandates for electronic prescribing, states are updating their requirements for physicians to check the prescription medicine monitoring program databases, says Kelly. Also, the DEA’s...
Medical Practice Compliance Alert
Larry P. Cote quoted in article “Prepare to Electronically Prescribe Controlled Substances”
Below is an excerpt:That’s despite the fact that EPCS is less susceptible to fraud and drug diversion, says attorney Larry Cote with Quarles & Brady in Washington, D.C. “It’s more secure than a paper prescription. People can’t make changes to...
Medical Practice Compliance Alert
Larry P. Cote quoted in article “FedEx Seeks to Show It’s Good Guy in Internet Drug Crackdown”
Below is an excerpt:FedEx won a ruling Thursday compelling the U.S. to hand over documents it says will show its “state of mind” and that it was acting in good faith. Such evidence may plant seeds of doubt in the...
Quarles & Brady’s Cote Is Subject Matter Expert in Drug Enforcement Administration (DEA) Compliance Online Training
MILWAUKEE, Wis. — The national law firm of Quarles & Brady LLP today announced that Larry Cote, managing partner of the firm's Washington, D.C. office and co-leader of its DEA Compliance & Litigation Practice Group, is the subject matter expert for...
Larry Cote quoted in article “The war on drugs comes to Corporate America”
Following is an excerpt:Larry Cote, an attorney and ex-associate chief counsel at the U.S. Drug Enforcement Administration who now advises companies on drug enforcement issues, said the following to Businessweek, “Targeting a company that’s two, three steps removed from the...
Larry Cote quoted in article “Feds in ‘Catch-22′ on D.C. Marijuana Legalization”
Following is an excerpt:Democrats representing jurisdictions that have voted to legalize recreational weed will roll out their congressional strategy Thursday, but federal drug regulators may be plotting to handcuff the first such ballot initiative sent to Congress...
Larry Cote quoted in article “FedEx Money-Laundering Charge Adds Pressure to Drug Case”
Following is an excerpt:Federal prosecutors are seeking to compel FedEx Corp. (FDX:US) to settle a pending drug-trafficking case by adding money-laundering charges against the parcel shipping company, attorneys and analysts said.“This looks like it’s a matter of ratcheting up the...
Larry Cote quoted in article “Cannabis Quandary for Firms”
Following is an excerpt:At the Washington office of Milwaukee-based Quarles & Brady, office managing partner Larry Cote said he has talked about the marijuana industry with his colleagues. Some are former U.S. Drug Enforcement Administration attorneys, and the firm advises...
The National Law Journal
Larry Cote quoted in article “Are Shippers Responsible for Legality of Goods They Transport?”
Following is an excerpt:
The Justice Department indicted FedEx earlier this month, charging conspiracy to distribute controlled substances because of the shipper's alleged role in transporting painkillers and other prescription drugs that had been sold illegally. FedEx is scheduled to be...
The Wall Street Journal
Larry Cote quoted in article “A Touchy Legal Question For FedEx, UPS: What’s in the Box?”
Larry Cote quoted in article “FedEx Indicted for Shipping Drugs for Online Pharmacies”
Following is an excerpt:FedEx Corp. was indicted for delivering prescription pain pills, sedatives, anti-anxiety drugs and other controlled substances for illegal Internet pharmacies.The criminal case is an unprecedented escalation of a federal crackdown on organizations and individuals to combat prescription...
Larry Cote quoted in article “DEA Classifies Tramadol as Schedule IV, Creating New Requirements for Drugmakers”
Following is an excerpt:Tramadol manufacturers have approximately 45 days to implement new labeling and security procedures now that the Drug Enforcement Administration has determined the opioid analgesic is a Schedule IV controlled substance."Now you will have at least a national...
Drug Industry Daily
Larry Cote featured in article “New MP Has DEA Roots”
Following is an excerpt:The new DC managing partner for Quarles & Brady has an exciting back story. (We're sure all you DC MPs have exciting histories... but not all of them could have been a plot onBreaking Bad.)At the DEA,...
Quarles & Brady Selects Larry Cote as Quarles & Brady D.C. Office Managing Partner
Washington, D.C. — The national law firm of Quarles & Brady
LLP and its firm chair Kimberly Leach
Johnson today announced that Larry P. Cote has been selected as the new Washington, D.C. office managing partner. His term began on January 6, 2014....
Blog: Quarles Announces DEA Chronicles Blog
MILWAUKEE, WIS. - The national law firm of Quarles & Brady LLP has announced its creation of a new blog -- DEA Chronicles -- focusing on DEA compliance.
Former DEA attorneys Larry Cote and Linden Barber will provide insight into emerging issues...
Clients and Public Officials Gather at Quarles Washington, D.C. Office
WASHINGTON, D.C. - The national law firm of Quarles & Brady LLP celebrated the opening of its Washington, D.C. office on Wednesday, September 12 with a reception at the firm's offices at 1700 K St. NW, in the nation's capital. The firm's...
Larry Cote Joins Quarles & Brady’s Washington, D.C. Office
WASHINGTON, D.C. - The national law firm of Quarles & Brady LLP announced that Larry P. Cote has joined the Firm's Washington, D.C. office as a partner in the Health Law Group.
"Larry's arrival furthers our efforts to build strong national presence in...